cytarabine has been researched along with Convulsions, Grand Mal in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dhall, G; Ettinger, LJ; Lastra, C; Mahadeo, KM; Panigrahy, A | 1 |
Aygun, N; Sherman, PM | 1 |
Barnett, MJ; Butler, MG; Ganesan, TS; Lister, TA; Richards, MA; Rohatiner, AZ; Slevin, ML; Smith, BF; Waxman, JH | 1 |
1 trial(s) available for cytarabine and Convulsions, Grand Mal
Article | Year |
---|---|
Central nervous system toxicity of high-dose cytosine arabinoside.
Topics: Adolescent; Adult; Aged; Central Nervous System Diseases; Cerebellar Diseases; Clinical Trials as Topic; Cytarabine; Dose-Response Relationship, Drug; Drug Evaluation; Epilepsy, Tonic-Clonic; Female; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Nystagmus, Pathologic; Syndrome; Tremor | 1985 |
2 other study(ies) available for cytarabine and Convulsions, Grand Mal
Article | Year |
---|---|
Subacute methotrexate neurotoxicity and cerebral venous sinus thrombosis in a 12-year-old with acute lymphoblastic leukemia and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: homocysteine-mediated methotrexate neurotoxicity via direct end
Topics: Amino Acid Substitution; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cytarabine; Daunorubicin; Endothelium, Vascular; Epilepsy, Tonic-Clonic; Genetic Predisposition to Disease; Humans; Hyperhomocysteinemia; Injections, Spinal; Leukoencephalopathies; Male; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Single Nucleotide; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Sinus Thrombosis, Intracranial; Vincristine | 2010 |
Development of a cavum septi pellucidi after Ommaya reservoir placement: report of an unusual complication.
Topics: Adult; Antimetabolites, Antineoplastic; Brain Neoplasms; Burkitt Lymphoma; Catheters, Indwelling; Cerebrospinal Fluid; Cerebrospinal Fluid Pressure; Cytarabine; Drug-Related Side Effects and Adverse Reactions; Epilepsy, Tonic-Clonic; Humans; Infusion Pumps, Implantable; Injections, Intraventricular; Lateral Ventricles; Magnetic Resonance Imaging; Male; Postoperative Complications; Reoperation; Septum Pellucidum; Tomography, X-Ray Computed; Treatment Outcome | 2006 |